The 2025 University Technology Transfer and Transformation Conference and the 2nd Suzhou International Sci-Tech Innovation Conference were held at Suzhou International Expo Center in SIP on July 10, as the 17th Suzhou Entrepreneurship Week for International Elites kicked off at the same time.
At the conferences, the Regional University--Industry Technology Transfer Center (Jiangsu) unveiled a list of significant cases of technology commercialization, including two from its Suzhou sub-center for biomedical technologies in SIP.
One of the cases is the project under the cooperation between the Suzhou sub-center and a team led by Prof. Zhu Di at Fudan University. The project, aimed at promoting innovation in therapeutic targeting of Wnt signaling pathway for treatment of liver cancer and digestive tract tumors, has won a RMB176 million investment contract from a domestic pharmaceutical company.
The other case is the 18F and 177Lu-FAPI radioligand therapy project from China Pharmaceutical University, which has attracted an investment of RMB50 million.
At the event, the Suzhou sub-center showcased its advantages, services, cooperation with global partners, and achievements.
July 11, 2025
